Innovative approaches to anti-arrhythmic drug therapy
- 1 December 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 5 (12) , 1034-1049
- https://doi.org/10.1038/nrd2112
Abstract
Normal cardiac function requires an appropriate and regular beating rate (cardiac rhythm). When the heart rhythm is too fast or too slow, cardiac function can be impaired, with derangements that vary from mild symptoms to life-threatening complications. Irregularities, particularly those involving excessively fast or slow rates, constitute cardiac 'arrhythmias'. In the past, drug treatment of cardiac arrhythmias has proven difficult, both because of inadequate effectiveness and a risk of serious complications. However, a variety of recent advances have opened up exciting possibilities for the development of novel and superior approaches to arrhythmia therapy. This article will review recent progress and future prospects for treating two particularly important cardiac arrhythmias: atrial fibrillation and ventricular fibrillation.Keywords
This publication has 160 references indexed in Scilit:
- The Mechanism of Atrial Antiarrhythmic Action of RSD1235Journal of Cardiovascular Electrophysiology, 2005
- A Kir2.1 gain-of-function mutation underlies familial atrial fibrillationBiochemical and Biophysical Research Communications, 2005
- Myocardial calcium signalling and arrhythmia pathogenesisBiochemical and Biophysical Research Communications, 2004
- Calstabin deficiency, ryanodine receptors, and sudden cardiac deathBiochemical and Biophysical Research Communications, 2004
- Pharmacological rescue of trafficking defective HERG channels formed by coassembly of wild-type and long QT mutant N470D subunitsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Long‐term restitution of 4‐aminopyridine‐sensitive currents in Kv1DN ventricular myocytes using adeno‐associated virus‐mediated delivery of Kv1.5FEBS Letters, 2003
- What is an antiarrhythmic drug? From clinical trials to fundamental conceptsThe American Journal of Cardiology, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Antiarrhythmic peptide has no direct cardiac actionsCellular and Molecular Life Sciences, 1989
- Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogsThe American Journal of Cardiology, 1977